PT Abadi Lestari Indonesia Tbk

PT Abadi Lestari Indonesia Tbk

IIDX:RLCO
3,250.00
IDR
+590.00
(+22.18%)
19.77TMarket Cap
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
121.43
149.74
169.72
284.47
- -
Basic EPS, GAAP
3.2
4
7.42
19.29
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
8.35
12.34
20.58
97.49
98.46
Tangible Book Value per Share
8.35
12.34
20.58
97.49
98.46
Basic Weighted Avg Shares
3,125
3,125
3,125
2,233
3,125
Sales/Revenue/Turnover
379,456
467,950
530,381
635,169
- -
Operating Margin (%)
7.85
8.95
10.69
13.47
- -
Depreciation Expense
1,365
1,087
1,032
1,034
- -
Net Income, GAAP
9,990
12,486
23,178
43,064
- -
Effective Tax Rate (%)
22.06
22.1
22.06
20.11
- -
Profit Margin (%)
2.63
2.67
4.37
6.78
- -
Working Capital
-47,659
-14,058
13,954
224,870
225,921
LT Debt
30,900
48,915
36,247
26,079
20,412
Total Equity
26,253
38,901
64,959
305,343
308,370
Return on Invested Capital (%)
- -
7.74
8.89
10.1
- -
Return on Capital (%)
- -
7.66
9.08
10.9
- -
Return on Common Equity (%)
- -
38.62
45.05
23.34
- -

Capital Structure

IDR

•

in mil. unless spec.
Mar'26
ST Debt
469,420
LT Borrowings
20,412
LT Finance Leases
- -
Preferred Equity and Hybrid Capital
- -
Shares Outstanding
3,125
Market Capitalization
19,765,625

Working Capital

IDR

•

in mil. unless spec.
Mar'26
Total Current Assets
708,261
Cash, Cash Equivalents & STI
68,357
Accounts Receivable, Net
301,819
Inventories
308,085
Total Current Liabilities
482,340
Payables & Accruals
- -
ST Debt
469,420
Deferred Revenue
- -

Growth Rates

IDR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
370.05%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
85.8%
Sales/Revenue/Turnover
- -
- -
19.76%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
530,381
2025
95,580
175,372
- -
- -
635,169
2026
92,268
179,741
- -
- -
- -

Quarterly Earnings Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
7.42
2025
1.05
5.38
- -
- -
19.29
2026
0.97
5.55
- -
- -
- -

Quarterly Dividends Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Edwin Pranata
Full Time Employees
225
Sector
Health technology
Industry
Pharmaceuticals: other
Address
East Java Indonesia
IPO Date
Dec 8, 2025
Business
PT Abadi Lestari Indonesia Tbk is an Indonesia-based consumer wellness and superfood enterprise engaged primarily in the processing, cleaning, manufacturing, and distribution of edible bird nest products and functional health food and beverages. The company operates an integrated business model spanning raw material processing to finished consumer packaged goods, offering a comprehensive product portfolio that includes cleaned, sorted, and vacuum-sealed raw edible bird nests; ready-to-drink formulated bird nest beverages enriched with collagen, amino acids, and vitamins under the flagship Fit With Realfood wellness program; edible bird nest jelly snack supplements under the Realfood Jelly brand; specialized nutritional formulas for children under the Momiku by Realfood brand; digestive wellness and dietary fiber drinks under the Realfood Cleanse line; ready-to-drink functional beverages under the Realfood Up brand; high-protein chicken broth and nutrient-dense formulations under the Wndrgreen brand; and value-added marine protein derivatives including frozen, dried, and processed aquatic food products. Founded in 2014 and headquartered in Bojonegoro, East Java, Indonesia, the company operates production and processing facilities in East Java and distributes its products across Indonesia through extensive retail and e-commerce networks, while exporting raw and processed bird nest products to international markets including China, Hong Kong, and the United States. PT Abadi Lestari Indonesia Tbk operates as a subsidiary of PT Realco Omega Investama and manages its consumer health manufacturing and commercialization activities through its principal subsidiary, PT Realfood Winta Asia. In recent major corporate developments, the company completed its Initial Public Offering on the Indonesia Stock Exchange in December 2025 under the ticker symbol RLCO, raising approximately IDR 105 billion to fund operational expansion and working capital requirements. Furthering its strategic shift from a traditional bird nest exporter into a multi-category health and superfood producer, the company established a new sub-subsidiary, PT Marinova Protein Internasional, in January 2026 to execute its business diversification into the processing, cold storage, and trade of marine-based protein products.